India  
NewsR.in
> >

Alcresta Therapeutics Announces Publication of Consensus Statement Supporting Access to RELiZORB®

Business Wire Tuesday, 25 June 2019
Alcresta Therapeutics Announces Publication of Consensus Statement Supporting Access to RELiZORB®WARREN, N.J.--(BUSINESS WIRE)--Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, announced the publication of a consensus statement supporting the clinical outcomes of RELiZORB® (immobilized lipase cartridge) and advocating for improved payer coverage and patient access. The consensus statement was published in the July issue of the Journal of Cystic Fibrosis and was signed by over 60 health care professionals
0
shares
ShareTweetSavePostSend
 

You Might Like


Other recent news in Press Releases

Apollo Endosurgery, Inc. to Report SECOND QUARTER Results on July 23, 2019Constellation SOFTWARE’s Total Specific Solutions Enters into Agreement to Acquire a European Provider of Vertical Market SOFTWARE
Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest